Close Menu

DrugMonkey doesn't think much of the new NIH rules to address financial conflict of interest among researchers. In fact, he says, the tighter rules "will do absolutely nothing about real COI." For one thing, DrugMonkey says, lowering the reporting threshold from $10,000 to $5,000 won't do anything about the PIs who caused scandal and were investigated by Congress for making hundreds of thousands of dollars from big pharma without reporting it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The World Health Organization will be providing low-cost COVID-19 tests to low- and middle-income nations, according to Reuters.

Nature News examines how the confirmation of Amy Coney Barrett to the US Supreme Court could affect scientific agencies.

Nobel Prize-winner Arthur Ashkin, who developed optical tweezers, has died at 98, the Washington Post reports.

In PNAS this week: altered gene expression in brain samples from Alzheimer's disease patients, effects of gene mutations found in bladder cancer, and more.